Securities fraud litigation history and active cases
Active Cases
0
Pending Settlement
1
Closed
0
Total Settlement
$33M
IMPAX LABORATORIES INC (IPXL) Class Action Lawsuit (November 2016)Pending Settlement
4:16cv6557 • November 11, 2016
Class Period Start
February 19, 2014
Class Period End
November 4, 2016
PSLRA Deadline
January 9, 2017
Case Allegations
10b5
Statutes of Repose
Feb 19, 2017
Country
United States
Court
Federal Court
Settlement Information
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
March 21, 2022
Settlement Fund
$33,000,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock or 2% Convertible Senior Notes of Impax Laboratories, Inc. (now known as Impax Laboratories, LLC) (“Impax” or the “Company”) from February 20, 2014 through August 9, 2016, inclusive.
Claim Administrator
JND Legal Administration
Impax Securities Settlement
c/o JND Legal Administration
PO Box 91417 Seattle, WA 98111
+1 833-823-0051
[email protected]
Settlement Website
https://www.impaxsecuritiessettlement.com/Hearing Date
March 31, 2022
Opt-out Deadline
March 4, 2022
Settlement Note
Download hereProof Of Claim
Download hereDocket History
TOP